在NSTE-ACS中评估侵入性干预的时间:从元分析和顺序试验评估的见解
Wei Yang1, Xiao-Zhen Ge1, Chong-Hui Wang2
1Department of Cardiology, Capital Medical University School of Rehabilitation Medicine, Beijing Bo'Ai Hospital, China Rehabilitation Research Center, Beijing, China.
Frontiers in cardiovascular medicine
|December 8, 2025
概括
对非ST升高急性冠状动脉综合征 (NSTE-ACS) 的早期侵入性治疗并不能降低死亡或心脏病发作风险. 然而,它显著减少了复发性缺血,改善了患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 临床试验 临床试验
背景情况:
- 非ST升高的急性冠状动脉综合征 (NSTE-ACS) 通常需要进行侵入性治疗,以减少心肌梗塞 (MI) 风险.
- 由于对长期结果的理解有限,NSTE-ACS中侵入性干预的最佳时间尚不清楚.
研究的目的:
- 评估早期与延迟侵入性干预时间对NSTE-ACS患者临床结果的影响.
- 评估干预时间对死亡率,心脏病发作,复发性缺血,再血管和重大出血的影响.
主要方法:
- 一项元分析,包括14项随机对照试验 (RCT) 的试验顺序分析 (TSA),涉及9,436名NSTE-ACS患者.
- 研究被分为早期 (<24小时) 和延迟 (≥24小时) 侵入性干预组,基于导管时间.
- 主要终点包括全因死亡或心脏病发作;次要终点包括复发性缺血,再血管和严重出血.
主要成果:
- 与延迟干预相比,早期干预并没有显著降低所有原因死亡率或心脏病发作率.
- 在早期和延迟干预组之间,没有发现重血管化或主要出血率的显著差异.
- 随着早期干预,人们观察到复发性缺血症的显著减少,这得到了TSA和长期随访的证实.
结论:
- 对于NSTE-ACS患者来说,早期的侵入性治疗不会改善存活率或降低心脏病发作率.
- 早期侵入性干预与NSTE-ACS患者中复发性缺血的发病率较低有关.
- 这些发现支持早期干预以减少复发性缺血,但不支持死亡率或心脏病发作.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
736
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
736
01:30Acute Coronary Syndrome III: Diagnostic Studies
199
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
199
01:28Acute Coronary Syndrome IV: Interprofessional Care
200
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
200
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
325
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325
01:26Acute Coronary Syndrome V: Nursing Management
249
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
249